References

1.     Roesler R, Henriques JA, Schwartsmann G. Gastrin-releasing peptide receptor as a molecular target for psychiatric and neurological disorders. CNS Neurol Disord Drug Targets. 2006;5:197-204. doi:10.2174/187152706776359673.

2.     Roesler R, Schwartsmann G. Gastrin-releasing peptide receptors in the central nervous system: role in brain function and as a drug target. Front Endocrinol (Lausanne). 2012;3:159. doi:10.3389/fendo.2012.00159.

3.     Degen LP, Peng F, Collet A, Rossi L, Ketterer S, Serrano Y, et al. Blockade of GRP receptors inhibits gastric emptying and gallbladder contraction but accelerates small intestinal transit. Gastroenterology. 2001;120:361-8. doi:10.1053/gast.2001.21174.

4.     Xiao D, Wang J, Hampton LL, Weber HC. The human gastrin-releasing peptide receptor gene structure, its tissue expression and promoter. Gene. 2001;264:95-103. doi:10.1016/s0378-1119(00)00596-5.

5.     Hildebrand P, Lehmann FS, Ketterer S, Christ AD, Stingelin T, Beltinger J, et al. Regulation of gastric function by endogenous gastrin releasing peptide in humans: studies with a specific gastrin releasing peptide receptor antagonist. Gut. 2001;49:23-8. doi:10.1136/gut.49.1.23.

6.     Gonzalez N, Moody TW, Igarashi H, Ito T, Jensen RT. Bombesin-related peptides and their receptors: recent advances in their role in physiology and disease states. Curr Opin Endocrinol Diabetes Obes. 2008;15:58-64. doi:10.1097/MED.0b013e3282f3709b.

7.     Jensen RT, Battey JF, Spindel ER, Benya RV. International Union of Pharmacology. LXVIII. Mammalian bombesin receptors: nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states. Pharmacol Rev. 2008;60:1-42. doi:10.1124/pr.107.07108.

8.     Weber HC. Regulation and signaling of human bombesin receptors and their biological effects. Curr Opin Endocrinol Diabetes Obes. 2009;16:66-71. doi:10.1097/med.0b013e32831cf5aa.

9.     Czepielewski RS, Porto BN, Rizzo LB, Roesler R, Abujamra AL, Pinto LG, et al. Gastrin-releasing peptide receptor (GRPR) mediates chemotaxis in neutrophils. Proc Natl Acad Sci U S A. 2012;109:547-52. doi:10.1073/pnas.1110996109.

10.   Neves SR, Ram PT, Iyengar R. G protein pathways. Science. 2002;296:1636-9. doi:10.1126/science.1071550.

11.   Cornelio DB, Roesler R, Schwartsmann G. Gastrin-releasing peptide receptor as a molecular target in experimental anticancer therapy. Ann Oncol. 2007;18:1457-66. doi:10.1093/annonc/mdm058.

12.   Sun HL, Ma QY, Bian HG, Meng XM, Jin J. Novel insight on GRP/GRPR axis in diseases. Biomed Pharmacother. 2023;161:114497. doi:10.1016/j.biopha.2023.114497.

13.   Duan H, Baratto L, Fan RE, Soerensen SJC, Liang T, Chung BI, et al. Correlation of (68)Ga-RM2 PET with Postsurgery Histopathology Findings in Patients with Newly Diagnosed Intermediate- or High-Risk Prostate Cancer. J Nucl Med. 2022;63:1829-35. doi:10.2967/jnumed.122.263971.

14.   Duan H, Moradi F, Davidzon GA, Liang T, Song H, Loening AM, et al. (68)Ga-RM2 PET-MRI versus MRI alone for evaluation of patients with biochemical recurrence of prostate cancer: a single-centre, single-arm, phase 2/3 imaging trial. Lancet Oncol. 2024;25:501-8. doi:10.1016/S1470-2045(24)00069-X.

15.   Korner M, Waser B, Rehmann R, Reubi JC. Early over-expression of GRP receptors in prostatic carcinogenesis. Prostate. 2014;74:217-24. doi:10.1002/pros.22743.

16.   Morgat C, MacGrogan G, Brouste V, Velasco V, Sevenet N, Bonnefoi H, et al. Expression of Gastrin-Releasing Peptide Receptor in Breast Cancer and Its Association with Pathologic, Biologic, and Clinical Parameters: A Study of 1,432 Primary Tumors. J Nucl Med. 2017;58:1401-7. doi:10.2967/jnumed.116.188011.

17.   Fleischmann A, Waser B, Gebbers JO, Reubi JC. Gastrin-releasing peptide receptors in normal and neoplastic human uterus: involvement of multiple tissue compartments. J Clin Endocrinol Metab. 2005;90:4722-9. doi:10.1210/jc.2005-0964.

18.   Sun B, Schally AV, Halmos G. The presence of receptors for bombesin/GRP and mRNA for three receptor subtypes in human ovarian epithelial cancers. Regul Pept. 2000;90:77-84. doi:10.1016/s0167-0115(00)00114-2.

19.   Mattei J, Achcar RD, Cano CH, Macedo BR, Meurer L, Batlle BS, et al. Gastrin-releasing peptide receptor expression in lung cancer. Arch Pathol Lab Med. 2014;138:98-104. doi:10.5858/arpa.2012-0679-OA.

20.   Gruber L, Decristoforo C, Uprimny C, Hohenberger P, Schoenberg SO, Orlandi F, et al. Imaging Properties and Tumor Targeting of (68)Ga-NeoBOMB1, a Gastrin-Releasing Peptide Receptor Antagonist, in GIST Patients. Biomedicines. 2022;10. doi:10.3390/biomedicines10112899.

21.   Rivera CA, Ahlberg NC, Taglia L, Kumar M, Blunier A, Benya RV. Expression of GRP and its receptor is associated with improved survival in patients with colon cancer. Clin Exp Metastasis. 2009;26:663-71. doi:10.1007/s10585-009-9265-8.

22.   Baratto L, Duan H, Laudicella R, Toriihara A, Hatami N, Ferri V, et al. Physiological (68)Ga-RM2 uptake in patients with biochemically recurrent prostate cancer: an atlas of semi-quantitative measurements. Eur J Nucl Med Mol Imaging. 2020;47:115-22. doi:10.1007/s00259-019-04503-4.

23.   Siegel RL, Giaquinto AN, Jemal A. Cancer statistics, 2024. CA Cancer J Clin. 2024;74:12-49. doi:10.3322/caac.21820.